ATLANTA, Ga-Officials from the Centers for Disease Control and Prevention (CDC) estimated that the hepatitis C virus (HCV) will be more lethal than AIDS by 2010.
The prediction comes only 12 years after the discovery of the blood-borne viral disease. Today, there are 10,000 people dying annually from HCV, with more than 200,000 people being treated for the virus. The CDC estimates that number will double within four years.
HCV, which is usually contracted through intravenous drug use or blood transfusions is only rarely passed through sexual intercourse. The problem in estimating how many Americans are currently afflicted with the virus stems in the disease's power to remain dormant for 20 years before causing liver failure.
Called the "silent killer," HCV can be treated by one drug on the market. Schering-Plough's Rebetron costs more than $18,000 annually. The drug is a combination of ribavirin and the anticancer drug interferon. They work together to trick the virus into creating defective viral cells.
This treatment is effective in 40% of cases, but also carries several side effects including depression and anemia.
Symptoms of HCV include jaundice, fatigue, and abdominal pain. The virus also scars the liver and can cause cancer.
Information from www.newsmax.com
Point-of-Care Engagement in Long-Term Care Decreasing Infections
November 26th 2024Get Well’s digital patient engagement platform decreases hospital-acquired infection rates by 31%, improves patient education, and fosters involvement in personalized care plans through real-time interaction tools.
Comprehensive Strategies in Wound Care: Insights From Madhavi Ponnapalli, MD
November 22nd 2024Madhavi Ponnapalli, MD, discusses effective wound care strategies, including debridement techniques, offloading modalities, appropriate dressing selection, compression therapy, and nutritional needs for optimal healing outcomes.
The Leapfrog Group and the Positive Effect on Hospital Hand Hygiene
November 21st 2024The Leapfrog Group enhances hospital safety by publicizing hand hygiene performance, improving patient safety outcomes, and significantly reducing health care-associated infections through transparent standards and monitoring initiatives.